Cost utility analysis of knee prosthesis with complete microprocessor control (C-leg) compared with mechanical technology in trans-femoral amputees

European Journal of Health Economics

Volumn 10, Issue 1, 2009, Pages 47-55

  Gerzeli, Simone ^a,b   Torbica, Aleksandra ^b   Fattore, Giovanni ^b  

^a UNIVERSITY OF PAVIA   (Italy)

^b BOCCONI UNIVERSITY   (Italy)

Author keywords

Amputees; C leg; Cost utility; EuroQol

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; ELECTRONICS; FEMALE; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; KNEE PROSTHESIS; MAJOR CLINICAL STUDY; MALE; MECHANICAL KNEE PROSTHESIS; MICROPROCESSOR; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY ADJUSTED LIFE YEAR; SOCIAL ASPECT;

ADULT; AMPUTEES; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; ITALY; KNEE PROSTHESIS; MALE; MIDDLE AGED; QUALITY-ADJUSTED LIFE YEARS; ROBOTICS;

EID: 58149086030     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-008-0102-9     Document Type: Article

References (29)

1. C.A. Brauer A.B. Rosen N.V. Olchanski P.J. Neumann 2005 Cost-utility analyses in orthopaedic surgery J. Bone Joint Surg. Am. 87 1253 1259
2. Global Lower Extremity Amputation Study Group 2000 Epidemiology of lower extremity amputation in centres in Europe, North America and East Asia Br. J. Surg. 87 328 337
3. D. Boyle D. Parker C. Larson L. Pessoa-Brandao 2000 Nature, incidence and cause of work-related amputations in Minnesota Am. J. Ind. Med. 37 542 550
4. T. Pohjolainen H. Alaranta 1999 Epidemiology of lower limb amputees in Southern Finland in 1995 and trends since 1984 Prosthet. Orthot. Int. 23 88 92
5. G.M. Rommers L.D. Vos J.W. Groothoff C.H. Schuiling W.H. Eisma 1997 Epidemiology of lower limb amputees in the north of The Netherlands: aetiology, discharge destination and prosthetic use Prosthet. Orthot. Int. 21 92 99
6. C.P. Van der Schans J.B. Geertzen T. Schoppen P.U. Dijkstra 2002 Phantom pain and health-related quality of life in lower limb amputees J. Pain Symptom Manage. 24 429 436
7. J.P. Pell P.T. Donnan F.G. Fowkes C.V. Ruckley 1993 Quality of life following lower limb amputation for peripheral arterial disease Eur. J. Vasc. Surg. 7 448 451
8. G.N. Weiss T.A. Gorton R.C. Read L.A. Neal 1990 Outcomes of lower extremity amputations J. Am. Geriatr. Soc. 38 877 883
9. M.W. Legro G. Reiber M. del Aquila M.J. Ajax D.A. Boone J.A. Larsen D.G. Simith B. Sangeorzan 1999 Issues of importance reported by persons with lower limb amputations and prostheses J. Rehabil. Res. Dev. 36 155 163
10. Evidence Based Practice Group (EBPG): A review of microprocessor- controlled knee prostheses (2003). Available from: URL: http://www.worksafebc. com/for_health_care_providers/Assets/PDF/Otto_Bock_Cleg.pdf. Accessed 17 October 2005
11. D. Datta B. Heller J. Howitt 2005 A comparative evaluation of oxygen consumption and gait pattern in amputees using intelligent prostheses and conventionally damped knee swing-phase control Clin. Rehabil. 19 398 403
12. T. Chin K. Machida S. Sawamura R. Shiba H. Oyabu Y. Nagakura I. Takase A. Nakagawa 2006 Comparison of different microprocessor controlled knee joints on the energy consumption during walking in trans-femoral amputees: intelligent knee prosthesis (IP) versus C-leg Prosthet. Orthot. Int. 30 73 80
13. J. Perry J.M. Burnfield C.J. Newsam P. Conley 2004 Energy expenditure and gait characteristics of a bilateral amputee walking with C-leg prostheses compared with stubby and conventional articulating prostheses Arch. Phys. Med. Rehabil. 10 1711 1717
14. Drummond, M.F., O'Brien, B.J., Stoddart, G.L., Torrance, G.W.: Methods for the Economic Evaluation of Health Care Programmes, 2nd edn. Oxford University Press, Oxford (1997)
15. Brooks, R.: EuroQol: the current state of play. Health Policy 37, 53-72 (1996)
16. www.euroqol.org
17. P. Dolan 1997 Modelling valuations for EuroQol health states Med. Care 35 1095 108
18. Gold, M.R., Siegel, J.R., Russel, L.B., Weinstein, M.C.: Cost-Effectiveness in Health and Medicine. Oxford University Press, New York (1996)
19. Informatore Farmaceutico. OEMF, Milano (2003)
20. Ministero della Sanità. Prestazioni di assistenza specialistica ambulatoriale erogabili nell'ambito del SSN e relative tariffe. Decreto Ministeriale del 22 Luglio 1996
21. C Lucioni MP Garancini M Massi-Benedetti S Mazzi G Serra 2000 Il costo sociale del diabete di tipo 2 in Italia: lo studio CODE-2 Pharmacoeconomics. Ital. Res. Artic. 2 1 21
22. J. Posnett S. Jan 1996 Indirect cost in economic evaluation: the opportunity cost of unpaid inputs Health Econ. 5 13 23
23. S. Gerzeli R. Tarricone P. Zolo I. Col angelo M.R. Busca C. Gandolfo 2006 The economic burden of stroke in Italy. The EcLIPSE study: economic longitudinal incidence-based project for stroke evaluation Neurol. Sci. 26 72 80
24. M.A. Koopmanschap F.F. Rutten 1993 Indirect costs in economic studies Pharmacoeconomics 4 446 454
25. Banca d'Italia. Note metodologiche e informazioni statistiche. I bilanci delle famiglia Italiane nell'anno 2000. Supplemential Bollettino Statistico (2002)
26. J.E. Siegel M.C. Weinstein L.B. Russell M.R. Gold 1996 Recommendations for reporting cost-effectiveness analyses. Panel on cost-effectiveness in health and medicine JAMA 276 1339 1341
27. M.C. Weinstein J.E. Siegel M.R. Gold M.S. Kamlet L.B. Russell 1996 Recommendations of the panel on cost-effectiveness in health and medicine JAMA 276 1253 1258
28. L.B. Russell M.R. Gold J.E. Siegel N. Daniels M.C. Weinstein 1996 The role of cost-effectiveness analysis in health and medicine. Panel on cost-effectiveness in health and medicine JAMA 276 1172 1177
29. H.G. Eichler S.X. Kong W.C. Gerth P. Mavros B. Jönsson 2004 Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge? Value Health 7 518 528